Expert Review of Anti-Infective Therapy

No easy way to exterminate ‘superbugs’ at the dawn of the third millennium
pp. 523-525(3)
Authors: Pirnay, Jean-Paul; De Vos, Daniel; Zizi, Martin; Heyman, Paul

News in Brief
pp. 527-530(4)

Disease Watch
pp. 530-531(2)

Itraconazole (Sporanox®) in superficial and systemic fungal infections
pp. 531-542(12)
Author: Caputo, R

Impact of supervised injection facilities on community HIV levels: a public health perspective
pp. 543-549(7)
Author: Tyndall, Mark W

Use of observational data in evaluating treatments: antiretroviral therapy and HIV
pp. 551-562(12)
Author: Ghani, Azra C

Cutaneous leishmaniasis: current and future management
pp. 563-570(8)
Author: Hepburn, Neill C

Chemotherapy for lymphatic filariasis: progress but not perfection
pp. 571-577(7)
Author: Melrose, Wayne D

New approaches to rapidly control foot-and-mouth disease outbreaks
pp. 579-586(8)
Author: Grubman, Marvin J

Host response to Neisseria meningitidis lacking lipopolysaccharides
pp. 589-596(8)
Author: Brandtzaeg, Petter

Pathogenesis of Guillain–Barré syndrome
pp. 597-608(12)
Authors: Tsang, Raymond SW; Valdivieso-Garcia, Alfonso

Pseudomonal infection in cystic fibrosis: the battle continues
pp. 609-618(10)
Authors: Elkin, Sarah; Geddes, Duncan

Current and future therapeutic approaches to the common cold
pp. 619-626(8)
Author: Mossad, Sherif B

Control of influenza virus infection by immunity to conserved viral features
pp. 627-638(12)
Author: Epstein, Suzanne L

Current diagnosis and treatment of infective endocarditis
pp. 639-654(16)
Authors: Tak, Tahir; Dhawan, Sumeesh; Reynolds, Cory; Shukla, Sanjay K

New therapeutic agents for resistant Gram-positive infections
pp. 655-665(11)
Authors: Ziglam, Hisham; Nathwani, Dillip

Bacterial biofilms: a diagnostic and therapeutic challenge
pp. 667-683(17)
Authors: Fux, Christoph A; Stoodley, Paul; Hall-Stoodley, Luanne; Costerton, J William